ACEBUTOLOL - 400 400 MG
ACEBUTOLOL (ACEBUTOLOL HYDROCHLORIDE) : 400 MG · DIN 02164426 · PRO DOC LIMITEE
Health Canada status: CANCELLED POST MARKET
What is ACEBUTOLOL - 400?
ACEBUTOLOL - 400 400 MG contains ACEBUTOLOL (ACEBUTOLOL HYDROCHLORIDE) : 400 MG. It is listed in the Health Canada Drug Product Database under DIN 02164426, held by PRO DOC LIMITEE, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 14-Jul-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02164426 |
|---|---|
| Brand name | ACEBUTOLOL - 400 |
| Generic / active ingredient | ACEBUTOLOL (ACEBUTOLOL HYDROCHLORIDE) : 400 MG |
| Manufacturer | PRO DOC LIMITEE |
| Strength | 400 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C07AB04 ACEBUTOLOL |
| AHFS class | 24:24.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 14-Jul-2022 |
| Original market date | 1996-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code C07AB04 ACEBUTOLOL. 6 of 44 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-ACEBUTOLOL | 100 MG | TABLET | APOTEX INC | MARKETED | DIN 02147602 |
| APO-ACEBUTOLOL | 200 MG | TABLET | APOTEX INC | MARKETED | DIN 02147610 |
| APO-ACEBUTOLOL | 400 MG | TABLET | APOTEX INC | MARKETED | DIN 02147629 |
| TEVA-ACEBUTOLOL | 100 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02204517 |
| TEVA-ACEBUTOLOL | 200 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02204525 |
| TEVA-ACEBUTOLOL | 400 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02204533 |
| ACEBUTOLOL | 100 MG | TABLET | SANIS HEALTH INC | CANCELLED POST MARKET | DIN 02286246 |
| ACEBUTOLOL | 200 MG | TABLET | SANIS HEALTH INC | CANCELLED POST MARKET | DIN 02286254 |
| ACEBUTOLOL | 400 MG | TABLET | SANIS HEALTH INC | CANCELLED POST MARKET | DIN 02286262 |
| ACEBUTOLOL-100 | 100 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02164396 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.